Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: Development and characterization

Drug Development and Industrial Pharmacy

Volumn 34, Issue 3, 2008, Pages 267-278

  Bruschi, Marcos Luciano ^a   De Freitas, Osvaldo ^a   Lara, Elza Helena Guimarães ^a   Panzeri, Heitor ^a   Gremião, Maria Palmira Daflon ^b   Jones, David Simon ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Paulist State University   (Brazil)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Intra periodontal pocket drug delivery systems; Periodontal disease; Precursor system of liquid crystalline phase; Propolis microparticles; Propolis release

Indexed keywords

GELATIN; HEXADECANOL; MYRISTIC ACID ISOPROPYL ESTER; PROCETYL AWS; PROPOLIS; SURFACTANT; UNCLASSIFIED DRUG;

ADHESION; ARTICLE; COMPRESSION; DRUG FORMULATION; DRUG RELEASE; FLOW KINETICS; HARDNESS; LIQUID CRYSTAL; MORPHOLOGY; PERIODONTAL DISEASE; SEDIMENTATION; SYRINGE; THIXOTROPY; TIME; VISCOSITY; YOUNG MODULUS;

ADHESIVENESS; ANTI-INFECTIVE AGENTS; DRUG DELIVERY SYSTEMS; FATTY ALCOHOLS; GELATIN; HARDNESS; LIQUID CRYSTALS; MYRISTATES; PERIODONTAL DISEASES; PROPOLIS; PROPYLENE GLYCOLS; RHEOLOGY; SURFACE-ACTIVE AGENTS; TEMPERATURE; VISCOSITY;

EID: 41149155926     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701655911     Document Type: Article

References (63)

1. Addy, M., & Langeroudi, M. (1984). Comparison of the immediate effects on the subgingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline. J. Clin. Periodontol., 11, 379-386.
2. Andrews, G. P., Gorman, S. P., & Jones, D. S. (2005). Rheological characterisation of primary and binary interactive bioadhesive gels composed of cellulose derivatives designed as ophthalmic viscosurgical devices. Biomaterials, 26, 571-580.
3. Barnes, H. A., Hutton, J. F., & Walters, K. (1989). An introduction to rheology. Amsterdam: Elsevier.
4. Bruschi, M. L., Cardoso, M. L. C., Lucchesi, M. B., & Gremião, M. P. D. (2003). Gelatin microparticles containing propolis obtained by spray-drying technique: Preparation and characterization. Int. J. Pharm., 264, 45-55.
5. Bruschi, M. L., & de Freitas, O. (2005). Oral bioadhesive drug delivery systems. Drug Dev. Ind. Pharm., 31, 293-310.
6. Bruschi, M. L., Franco, S. L., & Gremião, M. P. D. (2003). Application of an HPLC method for analysis of propolis extract. J. Liq. Chromatogr. Rel. Technol., 26, 2381-2391.
7. Bruschi, M. L., Lopes, R. S., Franco, S. L., & Gremião, M. P. D. (2004). In vitro release of propolis from gelatin microparticles prepared by spray-drying technique. Rev. Ciênc. Farm., 25, 79-84.
8. Bruschi, M. L., Martins, C. H. G., Vinholis, A. H. C., Casemiro, L. A., Panzeri, H., Gremião, M. P. D., et al. (2006). Preparation and antimicrobial activity of gelatin microparticles containing propolis against oral pathogens. Drug Dev. Ind. Pharm., 32, 229-238.
9. Bruschi, M. L., Panzeri, H., & Lara, E. H. G. (2005). Recent progress in research of propolis use in periodontology. Rev. ABO Nac., 13, 86-91.
10. Burdock, G. A. (1998). Review of the biological properties and toxicity of bee propolis (Propolis). Food Chem. Toxicol., 36, 347-363.
11. Ciancio, S. G. (1996). Medication as risk factors for periodontal disease. J. Periodontol., 67(10 suppl.), 1055-1059.
12. Croda. (2002). Folha de segurança de produto químico: Procetyl AWS. São Paulo, Brazil: Croda Chemicals Ltd.
13. Esposito, E., Cortesi, R., & Nastruzzi, C. (1996). Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials, 17, 2009-2020.
14. Falkiewicz, M. J. (1996). Theory of suspensions. In H. A. Lieberman, M. M. Rieger, & G. S. Banker (Eds.) Pharmaceutical dosage forms: Disperse systems (pp. 17-52). New York: Marcel Dekker, Inc.
15. Fiorellini, J. P., & Paquette, D. W. (1992). The potential role of controlled-release delivery systems for chemotherapeutic agents in periodontics. Curr. Opin. Dent., 2, 63-79.
16. Gabriëls, M., & Plaizier-Vercammen, J. (2004). Experimental designed optimisation and stability evaluation of dry suspensions with artemisinin derivatives for pediatric use. Int. J. Pharm., 283, 19-34.
17. Hao, J., & Heng, W. S. (2003). Buccal delivery systems. Drug Dev. Ind. Pharm., 29, 821-832.
18. Isla, M. I., Moreno, M. I. N., Sampietro, A. R., & Vattuone, M. A. (2001). Antioxidant activity of Argentine propolis extracts. J. Ethnopharmacol., 76, 165-170.
19. Jones, D. S., Brown, A. F., & Woolfson, A. D. (2001). Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: Transient and dynamic viscoelastic and continuous shear analysis. J. Pharm. Sci., 90, 1978-1990.
20. Jones, D. S., Irwin, C. R., Woolfson, A. D., Djokic, J., & Adams, V. (1999). Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J. Pharm. Sci., 88, 592-598.
21. Jones, D. S., Lawlor, M. S., & Woolfson, A. D. (2002). Examination of the flow rheological and textural properties of polymer gels composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone): Rheological and mathematical interpretation of textural parameters. J. Pharm. Sci., 91, 2090-2101.
22. Jones, D. S., Woolfson, A. D., & Brown, A. F. (1997a). Textural analysis and flow rheometry of bioadhesive, antimicrobial oral gels. Pharm. Res., 14, 450-457.
23. Jones, D. S., Woolfson, A. D., Brown, A. F. (1997b). Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int. J. Pharm., 151, 223-233.
24. Jones, D. S., Woolfson, A. D., Brown, A. F., Coulter, W. A., Mcclelland, C., & Irwin, C. R. (2000). Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J. Control. Release, 67, 357-368.
25. Jones, D. S., Woolfson, A. D., Brown, A. F., & O'Neill, M. J. (1997c). Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: In vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J. Control. Release, 49, 71-79.
26. Jones, D. S., Woolfson, A. D., & Djokic, J. (1996a). Texture profile analysis of bioadhesive polymeric semisolids: Mechanical characterization and investigation of interactions between formulation components. J. App. Pol. Sci., 61, 2229-2234.
27. Jones, D. S., Woolfson, A. D., Djokic, J., & Coulter, W. A. (1996b). Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res., 13, 1734-1738.
28. Kelly, H. M., Deasy, P. B., Ziaka, E., & Claffey, N. (2004). Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int. J. Pharm., 274, 167-183.
29. Koo, H., Gomes, B. P. F. A., Rosalen, P. L., Ambrosano, G. M. B., Park, Y. K., & Cury, J. A. (2000). In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch. Oral Biol., 45, 141-148.
30. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983). Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm., 15, 25-35.
31. Kujumgiev, A., Tsvetkova, I., Serkedjieva, Y., Bankova, V., Christov, R., & Popov., S. 1999. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol., 64, 235-240.
32. Lee, J., Young, S. A., & Kellaway, W. (2001). Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate. J. Pharm. Pharmacol., 53, 629-636.
33. Lindhe, J., Haffajee, A. J., & Socransky, S. S. (1983). Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J. Clin. Periodontol., 10, 433-442.
34. Lindhe, J., & Nyman, S. (1984). Long-term maintenance of patients treated for advanced periodontal disease. J. Clin. Periodontol., 11, 504-514.
35. Listgarten, M. A. (1987). Nature of periodontal disease: Pathogenic mechanisms. J. Periodontol. Res., 22, 172-178.
36. Löe, H., Theilade, E., & Jensen, S. B. (1965). Experimental gingivitis in man. J. Periodontol., 36, 177-187.
37. Malkin, A. Y. (1994). Fundamental topics in rheology: Rheology Fundamentals. Ontario, Canada: ChemTec Publishing.
38. Marcucci, M. C., Ferreres, F., García-Vigueira, C., Bankova, V. S., De Castro, S. L., Dantas, et al. (2001). Phenolic compounds from Brazilian propolis with pharmacological activities. J. Ethnopharmacol., 74, 105-112.
39. Marquele, F. D., Di Mambro, M., Georgetti, S. R., Casagrande, R., Valim, Y. M. L., & Fonseca, M. J. V. (2005). Assessment of the antioxidant activities of Brazilian extracts of propolis alone and in topical pharmaceutical formulations. J. Pharm. Biom. Anal., 39, 455-462.
40. Martin, A., Bustamente, P., & Chun, A. H. C. (1993). Physical Pharmacy. London: Lea & Febiger.
41. Medlicott, N. J., Rathbone, M. J., Tucker, I. G., & Holborow, D. W. (1994). Delivery systems for the administration of drugs to the periodontal pocket. Adv. Drug Deliv. Rev., 13, 181-203.
42. Moreno, M. I. N., Isla, M. I., Cudmani, N. G., Vattuone, M. A., & Sampietro, A. R. (1999). Screening of antibacterial activity of Amaicha del Valle (Tucumán, Argentina) propolis. J. Ethnopharmacol., 68, 97-102.
43. Nagai, T., Sakai, M., Inoue, R., Inoue, H., & Suzuki, N. (2001). Antioxidative activities of some commercial honeys, royal jelly, and propolis. Food Chem., 75, 237-240.
44. Nakamoto, R. Y. (1979). Use of saliva substitute in post-radiation xerostomia. J. Prosthetic. Dent., 42, 539-542.
45. Norling, T., Lading, P., Engstron, S., Larsson, K., Krog, N., & Missen, S. S. (1992). Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J. Clin. Periodontol., 19, 687-692.
46. Okonogi, S., Khongkhunthain, S., Bunyaratavej, P., Thusaphorn, T., & Umpriwan, R. (2004). Development of local injectable dental gel: The influence of certain additives on physicochemical properties of glycerylmonooleate-based formulations. Drug Dev. Ind. Pharm., 30, 347-357.
47. Patel, N. K., Kennon, L., & Levinson, R. S. (2001). Suspensões. In L. Lachman, H. A. Lieberman, & J. L. Kanig (Eds.) Teoria e Prática na Indústria Farmacêutica (pp. 819-854). Lisbon, Portugal: Calouste Gulbekian Fundation.
48. Perioli, L., Ambrogi, V., Rubini, D., Giovagnoli, S., Ricci, M., Blasi, P., et al. (2004). Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J. Control. Release, 95, 521-533.
49. Repka, M. A., Prodduturi, S., & Stodhill, S. P. (2003). Production of hot-melt extruded films containing clotrimazole. Drug Dev. Ind. Pharm, 29, 757-765.
50. Ritger, P. L., & Peppas, N. A. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release, 5, 37-42.
51. Santos, F. A., Bastos, E. M. A., Rodrigues, P. H., Uzeda, M., de Carvalho, M. A. R., Farias, L. M., et al. (2002a). Susceptibility of Prevotella intermedia/Prevotella nigrescens (and Porphyromonas gingivalis) to propolis (bee glue) and other antimicrobial agents. Anaerobe, 8, 9-15.
52. Santos, F. A., Bastos, E. M. A., Uzeda, M., Carvalho, M. A. R., Farias, L. M., Moreira, E. S. A., et al. (2002b). Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J. Ethnopharmacol., 80, 1-7.
53. Sforcin, J. M., Fernandes Jr., A., Lopes, C. A. M., Bankova, V., & Funari, S. R. C. (2000). Seasonal effect on Brazilian propolis antibacterial activity. J. Ethnopharmacol., 73, 243-249.
54. Slots, J. (1979). Subgingival microflora and periodontal disease. J. Clin. Periodontol., 6, 351-382.
55. Song, Y. S., Park, E., Hur, G. M., Ryu, Y. S., Lee, Y. S., Lee, J.Y., et al. (2002a). Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett., 175, 53-61.
56. Song, Y. S., Park, E., Hur, G. M., Ryu, Y. S., Kim, Y. M., & Jin, C. (2002b). Ethanol extract of propolis inhibits nitric oxide synthase gene expression and enzyme activity. J. Ethnopharmacol., 80, 155-161.
57. Soskolone, W. A., & Freidman, M. F. (1996). Intra-periodontal pocket drug delivery systems. In M. J. Rathbone (Ed.), Oral mucosal drug delivery (pp. 359-379). New York: Marcel Dekker, Inc.
58. Stoltze, K., & Stellfed, M. (1992). Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. J. Clin. Periodontol., 19, 693.
59. Urban, M. C. C., Bruschi, M. L., Chiavacci, L. A., & Gremião, M. P. D. (2004). Development and physical characterization of non-ionic microemulsions containing PPG-5-Ceteth-20. Surfactants In Solution Symposium, 15.
60. Van Der Ouderaa, F. J. G. (1991). Anti-plaque agents: Rationale and prospects for prevention of gingivitis and periodontal disease. J. Clin. Periodontol., 18, 447-454.
61. Van Winkelhoff, A. J., Vangsted, T., & Winkel, E. G. (2000). Metronidazole in the treatment of refractory periodontitis. Ned. Tijdschr. Tandheelkd., 107, 327-331.
62. Wolff, L., Dahlen, G., & Aeppli, D. (1994). Bacteria as risk markers for periodontitis. J. Periodontol., 65(5 suppl.), 498-510.
63. Woolfson, A. D., Malcon, R. K., Campbell, K., Jones, D. S., & Russell, J. A. (2000). Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J. Control. Release, 67, 395-408.